Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Joel Uzzan"'
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 9, Pp 2445-2465 (2024)
Abstract Introduction Anti-vascular endothelial growth factor (VEGF) agents have been the standard treatment for retinal diseases for almost two decades. These treatments are administered via intravitreal injection using single-use vials or prefilled
Externí odkaz:
https://doaj.org/article/d626dbc39490404587ebff584e9b9ee6
Autor:
Meryem Filali Ansary, Emanuele Crincoli, Oudy Semoun, Joel Uzzan, Francesca Amoroso, Camille Jung, Alexandra Miere, Eric Souied
Publikováno v:
Medicina, Vol 58, Iss 9, p 1246 (2022)
Background and Objectives: The aim of this study was to report the characteristics of macular neovascularization (MNV) with undetectable flow on optical coherence tomography angiography (OCTA) in neovascular age related macular degeneration (nAMD), a
Externí odkaz:
https://doaj.org/article/449e410ec27742308827d10231100797
Autor:
Stéphanie Baillif, E. Fourmaux, Jean-François Le Rouic, Thi Ha Chau Tran, Ali Erginay, Joel Uzzan, Stephane Verdun, Solange Milazzo, Laurent Kodjikian
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Thi Ha Chau Tran,1 Ali Erginay,2 Stephane Verdun,3 Eric Fourmaux,4 Jean-François Le Rouic,5 Joel Uzzan,6 Solange Milazzo7 ,† Stephanie Baillif,8 Laurent Kodjikian9 1Service d’Ophtalmologie, Université Catholique de Lille, Faculté de Médecine
Autor:
Thi Ha Chau Tran, Stephane Verdun, Jean François Le Rouic, Joel Uzzan, Solange Milazzo, Laurent Kodjikian, Ali Erginay
Publikováno v:
Clinical Ophthalmology.
Thi Ha Chau Tran,1 Stephane Verdun,2 Jean François Le Rouic,3 Joel Uzzan,4 Solange Milazzo5 ,† Laurent Kodjikian,6 Ali Erginay7 1Ophthalmology Department, Lille Catholic Hospitals, Lille Catholic University, INSERM, U1172, Lille, France; 2Biostati
Autor:
Evelyne Decullier, Laure Huot, Stéphane Dumas, Thibaud Mathis, Ramin Tadayoni, Eric H Souied, Laurent Kodjikian, Joel Uzzan, Stéphanie Baillif, Solange Milazzo, Lorraine Bernard
Publikováno v:
Retina (Philadelphia, Pa.). 42(2)
To evaluate the mean change in visual acuity at 52 weeks in patients with idiopathic choroidal neovascularization treated with aflibercept.We conducted a prospective noncomparative open-label Phase-II trial. The dosage regimen evaluated in this study
Autor:
Maddalena Quaranta-ElMaftouhi, Eric H. Souied, Stéphane Béchet, Florence Coscas, Camille Jung, Jean-François Korobelnik, José Sahel, Joel Uzzan, Giuseppe Querques, Rocio Blanco-Garavito
Publikováno v:
Retina (Philadelphia, Pa.)
Treatment-resistant pigment epithelial detachments can be effectively treated with aflibercept switch therapy. Patients were treated with 3 monthly intravitreal injections and then a Q6 regimen. Mean pigment epithelial detachment height and volume we
Autor:
Joel Uzzan, Dafna Goldenberg, Florence Coscas, Anat Loewenstein, Qienyuan Zhou, Umberto De Benedetto, Marco Rispoli, Gabriel Coscas, Maria Cristina Savastano, Ilaria Zucchiatti, Bruno Lumbroso, Kelly Soules
Publikováno v:
European Journal of Ophthalmology. 22:992-1000
Purpose. To evaluate choroid thickness (CT) with RTVue spectral domain optical coherence tomography (SD-OCT) and the effect of age and myopia in eyes without posterior complications. Methods. In this multicenter cross-sectional study, all enrolled pa
Autor:
Marco Lupidi, Florence Coscas, Violaine Caillaux, Gabriel Coscas, Agnès Glacet-Bernard, Eric H. Souied, Alexandra Miere, Joel Uzzan
Publikováno v:
American journal of ophthalmology. 161
Purpose To evaluate the optical coherence tomography angiography (OCT angiography) appearance of the superficial and deep capillary plexa in eyes with retinal vein occlusion (RVO) and to compare these findings with those of fluorescein angiography (F
Autor:
Julien Pérol, Catherine Français, Carole Burillon, Jean-François Korobelnik, Stéphanie Baillif, Laurent Berthon, Giuseppe Querques, M. Boissonnot, Jean-Paul Berrod, Catherine Creuzot-Garcher, Christiane Besse Ramahefasolo, Florence Coscas, Olivier Chevreaud, Christophe Chiquet, Maher Saleh, G Chaine, Pierre-Jean Pisella, Morgane Straub, John Conrath, Jean-François Girmens, Laurent Kodjikian, Joel Uzzan, Franck Fajnkuchen, Salomon Y. Cohen, Alain M. Bron, Yannick Le Mer, Marie-Noëlle Delyfer, Typhaine Grenet, Eric H Souied, Denis Dossarps, Bernard Delbosc, David Gaucher, Philippe Koehrer, Ludwig S. Aho-Glélé, Cécile Musson, Marc Muraine, Amina Bakhti, Quaranta-El Maftouhi, Audrey Giocanti, Nicolas Leveziel, Vincent Fortoul, Sam Razavi, Marie-Laure Le Lez
Publikováno v:
Annual meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
Annual meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), May 2015, Rockville, United States
American Journal of Ophthalmology
American Journal of Ophthalmology, Elsevier Masson, 2015, 160 (1), pp.17-25.e1. ⟨10.1016/j.ajo.2015.04.013⟩
Annual meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), May 2015, Rockville, United States
American Journal of Ophthalmology
American Journal of Ophthalmology, Elsevier Masson, 2015, 160 (1), pp.17-25.e1. ⟨10.1016/j.ajo.2015.04.013⟩
Purpose To report the incidence and characteristics of endophthalmitis after intravitreal injections of anti–vascular endothelial growth factor agents or corticosteroids and to describe the clinical and bacteriologic characteristics, management, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8700a99d72fa6222e7f2c9009c1fd8dc
https://hal.archives-ouvertes.fr/hal-01241069
https://hal.archives-ouvertes.fr/hal-01241069
Publikováno v:
Retina (Philadelphia, Pa.). 32(8)
To identify the causes of loss of vision after ranibizumab therapy in patients with exudative age-related macular degeneration treated in three clinical settings.A retrospective multicentric analysis of 290 consecutive eyes comprising cohorts from 3